| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.3 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.047 | 0.3 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.3 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |